Our Services
Medical Information
Helpful Resources
Published on: 9/15/2026
Yes, bupropion can trigger anxiety, restlessness, and agitation that escalates into a panic attack, and in rarer cases it can lower the seizure threshold, particularly at higher doses, with rapid dose increases, or in people with eating disorders, alcohol withdrawal, or a seizure history. Panic attacks and seizures feel very different, but overlapping symptoms like racing heart, shaking, and confusion can make them hard to tell apart in the moment. Dose, formulation, timing, and other medications or stimulants all change your level of risk. There are several important warning signs and risk factors to consider, so see below to understand more before assuming your symptoms are "just anxiety."
If your heart is pounding, your thoughts are spiraling, or you had an episode you cannot fully explain, a few minutes of clarity can help you decide whether this needs urgent care or a conversation with your prescriber. Take a free, instant, online symptom check to see which conditions match what you are experiencing and what your most sensible next step looks like.
Last reviewed for medical accuracy: 09/15/2026
Bupropion is a widely prescribed antidepressant and smoking‐cessation aid. While many people tolerate it well, a subset report increased anxiety. Understanding whether this side effect can escalate into panic attacks or seizures is important for anyone taking bupropion or considering it.
Bupropion acts on brain chemicals to help improve mood and reduce cravings. Key points:
Because bupropion has a mild stimulant effect, some people feel jittery or more alert in the first few weeks.
In clinical trials, up to 10 percent of people report new or worsened anxiety when starting bupropion. Common features include:
Most cases are mild and resolve within 1–2 weeks as the body adjusts. If anxiety persists beyond a month or significantly interferes with daily life, it’s worth discussing with your prescriber.
A panic attack is an abrupt surge of intense fear or discomfort, peaking within minutes. Symptoms may overlap with general anxiety but are more intense:
Can bupropion-induced anxiety become a panic attack? Yes, especially if:
Adjusting the dose, switching to the XL formulation, or adding a short course of a low-dose benzodiazepine (under medical supervision) can reduce panic risk.
Bupropion lowers the brain’s seizure threshold more than most other antidepressants. Key facts:
If you have any of these risk factors, your doctor may choose a different antidepressant or start bupropion at a lower dose with very slow titration.
While panic attacks and certain seizure types share overlap (e.g., shaking, altered awareness), there are distinguishers:
Panic Attack
Seizure
If you’re unsure which episode you experienced, medical evaluation (and sometimes an EEG) can clarify the cause.
If you notice heightened anxiety after starting or increasing bupropion, consider these steps:
In many cases, anxiety settles down as you adjust. If it doesn’t, your prescriber may add a short-term anxiolytic or choose an alternative antidepressant.
Seizures are uncommon on standard bupropion doses but can be serious. Seek immediate care if you experience:
If any of these occur, call emergency services or have someone take you to the nearest emergency department.
Your mental and physical safety come first. Talk to a healthcare provider if you experience:
You might also consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker to get personalized guidance on next steps.
Open communication helps your doctor tailor treatment:
This information guides safer dosing decisions and helps rule out other causes.
Bupropion offers many benefits:
However, like all medications, it carries trade-offs. Most people tolerate bupropion without severe anxiety or seizures, but knowing the warning signs and risk factors keeps you safer.
If you have any life-threatening or serious symptoms, please speak to a doctor right away. Your safety and well-being are the top priority.
(References)
* Dufresne RL, Weber SS, Becker RE. Bupropion hydrochloride. Drug Intell Clin Pharm. 1984 Dec;18(12):957-64. doi: 10.1177/106002808401801201. PMID: 6439541.
* Shepherd G, Velez LI, Keyes DC. Intentional bupropion overdoses. J Emerg Med. 2004 Aug;27(2):147-51. doi: 10.1016/j.jemermed.2004.02.017. PMID: 15261357.
* Cahill K, Stevens S, Perera R, Lancaster T. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev. 2013 May 31;2013(5):CD009329. doi: 10.1002/14651858.CD009329.pub2. Epub 2013 May 31. PMID: 23728690; PMCID: PMC8406789.
* Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, Sharma V, Goldstein BI, Rej S, Beaulieu S, Alda M, MacQueen G, Milev RV, Ravindran A, O'Donovan C, McIntosh D, Lam RW, Vazquez G, Kapczinski F, McIntyre RS, Kozicky J, Kanba S, Lafer B, Suppes T, Calabrese JR, Vieta E, Malhi G, Post RM, Berk M. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018 Mar;20(2):97-170. doi: 10.1111/bdi.12609. Epub 2018 Mar 14. PMID: 29536616; PMCID: PMC5947163.
* Costa R, Oliveira NG, Dinis-Oliveira RJ. Pharmacokinetic and pharmacodynamic of bupropion: integrative overview of relevant clinical and forensic aspects. Drug Metab Rev. 2019 Aug;51(3):293-313. doi: 10.1080/03602532.2019.1620763. Epub 2019 Jun 14. PMID: 31124380.
* Naguy A, Badr BHM. Bupropion-myth-busting! CNS Spectr. 2022 Oct;27(5):545-546. doi: 10.1017/S1092852921000365. Epub 2021 Apr 12. PMID: 33843549.
* Alberter AA, Chambers AJ, Schaffer DH. Bupropion Toxicity. 2026 Jan. PMID: 35593803.
* Naguy A, Pridmore S, Alamiri B. Bupropion-Associated Seizures. Am J Ther. 2024 May-Jun 01;31(3):e331-e332. doi: 10.1097/MJT.0000000000001669. Epub 2023 Oct 16. PMID: 38091263.
* Manter MA, Birtwell KB, Bath J, Friedman NDB, Keary CJ, Neumeyer AM, Palumbo ML, Thom RP, Stonestreet E, Brooks H, Dakin K, Hooker JM, McDougle CJ. Pharmacological treatment in autism: a proposal for guidelines on common co-occurring psychiatric symptoms. BMC Med. 2025 Jan 7;23(1):11. doi: 10.1186/s12916-024-03814-0. Epub 2025 Jan 7. PMID: 39773705; PMCID: PMC11705908.
* Oldak SE, Maristany AJ. Bupropion and Anxiety: A Brief Review. Hum Psychopharmacol. 2025 Sep;40(5):e70018. doi: 10.1002/hup.70018. PMID: 40958494.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.